TY - JOUR
T1 - Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold
AU - Chen, Xin
AU - Yang, Yanchun
AU - Ma, Bing
AU - Zhang, Shuzhen
AU - He, Minlan
AU - Gui, Dequan
AU - Hussain, Saghir
AU - Jing, Chaojun
AU - Zhu, Changjin
AU - Yu, Qun
AU - Liu, Yan
PY - 2011/5
Y1 - 2011/5
N2 - A series of pyrido[2,3-e]-[1,2,4]-thiadiazine 1,1-dioxide acetic acid derivatives were synthesized and tested for their inhibitory activity against aldose reductase (ALR2). These derivatives were found to be potent aldose reductase inhibitors with IC50 values ranging from 0.038 μM to 11.29 μM. Most but not all of them showed a strong ALR2 inhibition activity and significant selectivity, which were further supported by docking studies. Of these inhibitors, compound 7d exhibited highest inhibition activity. Structure-activity relationship studies indicate the requirement of N2-benzyl group with electron-withdrawing substituents and N4-acetic acid group in the pyridothiadiazine scaffold.
AB - A series of pyrido[2,3-e]-[1,2,4]-thiadiazine 1,1-dioxide acetic acid derivatives were synthesized and tested for their inhibitory activity against aldose reductase (ALR2). These derivatives were found to be potent aldose reductase inhibitors with IC50 values ranging from 0.038 μM to 11.29 μM. Most but not all of them showed a strong ALR2 inhibition activity and significant selectivity, which were further supported by docking studies. Of these inhibitors, compound 7d exhibited highest inhibition activity. Structure-activity relationship studies indicate the requirement of N2-benzyl group with electron-withdrawing substituents and N4-acetic acid group in the pyridothiadiazine scaffold.
KW - Acetic acid derivative
KW - Aldose reductase
KW - Inhibitor
KW - Pyrido[2,3e]-[1,2,4]-thiadiazine
UR - http://www.scopus.com/inward/record.url?scp=79953226757&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2011.01.072
DO - 10.1016/j.ejmech.2011.01.072
M3 - Article
C2 - 21367494
AN - SCOPUS:79953226757
SN - 0223-5234
VL - 46
SP - 1536
EP - 1544
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
IS - 5
ER -